Imaging tools for the clinical assessment of idiopathic inflammatory myositis

Current Opinion in Rheumatology

Volumn 20, Issue 6, 2008, Pages 656-661

  Walker, Ulrich A ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

MRI; Myositis; Radionuclide imaging; Skeletal muscle; Ultrasound

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GALLIUM 67; INDIUM 111; PYROPHOSPHATE TECHNETIUM TC 99M;

BLOOD OXYGENATION; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DERMATOMYOSITIS; DIFFUSION WEIGHTED IMAGING; DOPPLER FLOWMETRY; HUMAN; INCLUSION BODY MYOSITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMYOSITIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SCINTIGRAPHY; SENSITIVITY AND SPECIFICITY; ULTRASOUND;

BIOPSY; DERMATOMYOSITIS; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MYOSITIS; MYOSITIS, INCLUSION BODY; POLYMYOSITIS; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 56249088674     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/BOR.0b013e3283118711     Document Type: Review

References (53)

1. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003; 362:971-982.
2. Maillard SM, Jones R, Owens C, et al. Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis. Rheumatology 2004; 43:603-608.
3. Connor A, Stebbings S, Anne HN, et al. STIR MRI to direct muscle biopsy in suspected idiopathic inflammatory myopathy. J Clin Rheumatol 2007; 13:341-345.
4. O'Connell MJ, Powell T, Brennan D, et al. Whole-body MR imaging in the diagnosis of polymyositis. AJR Am J Roentgenol 2002; 179:967-971.
5. Cantwell C, Ryan M, O'Connell M, et al. A comparison of inflammatory myopathies at whole-body turbo STIR MRI. Clin Radiol 2005; 60:261-267; DA - 20050124.
6. Parker L, Nazarian LN, Carrino JA, et al. Musculoskeletal imaging: medicare use, costs, and potential for cost substitution. J Am Coll Radiol 2008;5:182-188. An analysis of the temporal trends of MRI costs in comparison with those of other imaging modalities in the diagnosis of musculoskeletal disorders, concluding that the substitution of ultrasound for MRI, when appropriate, would lead to savings of several billion dollars in the next decade.
7. Reimers CD, Fleckenstein JL, Witt TN, et al. Muscular ultrasound in idiopathic inflammatory myopathies of adults. J Neurol Sci 1993; 116:82-92.
8. Reimers CD, Finkenstaedt M. Muscle imaging in inflammatory myopathies. Curr Opin Rheumatol 1997; 9:475-485.
9. Weber MA, Krakowski-Roosen H, Delorme S, et al. Relationship of skeletal muscle perfusion measured by contrast-enhanced ultrasonography to histologic microvascular density. J Ultrasound Med 2006; 25:583-591.
10. Krix M, Weber MA, Krakowski-Roosen H, et al. Assessment of skeletal muscle perfusion using contrast-enhanced ultrasonography. J Ultrasound Med 2005; 24:431-441.
11. Weber MA, Krix M, Jappe U, et al. Pathologic skeletal muscle perfusion in patients with myositis: detection with quantitative contrast-enhanced US - initial results. Radiology 2006; 238:640-649.
12. Weber MA, Jappe U, Essig M, et al. Contrast-enhanced ultrasound in dermatomyositis- and polymyositis. J Neurol 2006; 253:1625-1632.
13. Batz R, Sofka CM, Adler RS, et al. Dermatomyositis and calcific myonecrosis in the leg: ultrasound as an aid in management. Skeletal Radiol 2006; 35:113-116.
14. Fayad LM, Carrino JA, Fishman EK. Musculoskeletal infection: role of CT in the emergency department. Radiographics 2007; 27:1723-1736.
15. Carrino JA, Blanco R. Magnetic resonance: guided musculoskeletal interventional radiology. Semin Musculoskelet Radiol 2006; 10:159-174.
16. Dion E, Cherin P, Payan C, et al. Magnetic resonance imaging criteria for distinguishing between inclusion body myositis and polymyositis. J Rheumatol 2002; 29:1897-1906.
17. Tomasova Studynkova J, Charvat F, Jarosova K, Vencovsky J. The role of MRI in the assessment of polymyositis and dermatomyositis. Rheumatology 2007; 46:1174-1179. A study comparing muscle biopsies from inflammatory and noninflammatory sites as identified by MRI.
18. Kimball AB, Summers RM, Turner M, et al. Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis. Implications for diagnosis and therapy. Arthritis Rheum 2000; 43:1866-1873.
19. Carrera E, Lobrinus JA, Spertini O, et al. Dermatomyositis, lobar panniculitis and inflammatory myopathy with abundant macrophages. Neuromuscul Disord 2006; 16:468-471.
20. Prendergast M, Hopkinson N. Breast calcinosis, panniculitis and fat hypertrophy in a 35-year-old woman with dermatomyositis. Rheumatology (Oxford) 2007;46:1378-1379.
21. Samson C, Soulen RL, Gursel E. Milk of calcium fluid collections in juvenile dermatomyositis: MR characteristics. Pediatr Radiol 2000; 30:28-29.
22. Maillard SM, Jones R, Owens CM, et al. Quantitative assessments of the effects of a single exercise session on muscles in juvenile dermatomyositis. Arthritis Rheum 2005; 53:558-564.
23. Misu T, Tateyama M, Nakashima I, et al. Relapsing focal myositis: the localization detected by gallium citrate Ga 67 scintigraphy. Arch Neurol 2005; 62:1930-1931.
24. Hoffmann A, Buitrago TC, Tolnay M, et al. Focal myositis of the iliopsoas muscle - a benign pseudotumour: ultrasound appearance in correlation with CT and MRI. Ultraschall Med 2006; 27:180-184.
25. Kawarai T, Nishimura H, Taniguchi K, et al. Magnetic resonance imaging of biceps femoris muscles in benign acute childhood myositis. Arch Neurol 2007; 64:1200-1201.
26. Panghaal V, Ortiz-Romero S, Lovinsky S, Levin TL. Benign acute childhood myositis: an unusual cause of calf pain. Pediatr Radiol 2008; 38:703-705.
27. Cea G, Bendahan D, Manners D, et al. Reduced oxidative phosphorylation and proton efflux suggest reduced capillary blood supply in skeletal muscle of patients with dermatomyositis and polymyositis: a quantitative 31P-magnetic resonance spectroscopy and MRI study. Brain 2002; 125:1635-1645.
28. 31P magnetic resonance spectroscopy. Rheumatology (Oxford) 2004; 43:696-703.
29. Nuutila P, Kalliokoski K. Use of positron emission tomography in the assessment of skeletal muscle and tendon metabolism and perfusion. Scand J Med Sci Sports 2000; 10:346-350.
30. Liau N, Ooi C, Reid C, et al. F-18 FDG PET/CT detection of mediastinal malignancy in a patient with dermatomyositis. Clin Nucl Med 2007; 32:304-305.
31. Munoz MA, Conejo-Mir JS, Congregado-Loscertales M, et al. The utility of positron emission tomography to find an occult neoplasm in a patient with dermatomyositis. J Eur Acad Dermatol Venereol 2007; 21:1418-1419.
32. 18F FDG PET scans in 137 patients with sarcoidosis but found muscle involvement in only six individuals.
33. Dufour JF, Billotey C, Streichenberger N, et al. Sarcoidosis demonstrated by fluorodeoxyglucose positron emission tomography in a case of granulomatous myopathy. Rev Med Interne 2007; 28:568-570.
34. Slart RH, Jager PL, Poot L, et al. Clinical value of gallium-67 scintigraphy in assessment of disease activity in Wegener's granulomatosis. Ann Rheum Dis 2003; 62:659-662.
35. Otake S, Ishigaki T. Muscular sarcoidosis. Semin Musculoskelet Radiol 2001; 5:167-170.
36. Cherin P, Authier FJ, Gherardi RK, et al. Gallium-67 scintigraphy in macrophage myofasciitis. Arthritis Rheum 2000; 43:1520-1526.
37. Gherardi RK, Coquet M, Cherin P, et al. Macrophagic myofasciitis: an emerging entity. Groupe d'Etudes et Recherche sur les Maladies Musculaires Acquises et Dysimmunitaires (GERMMAD) de l'Association Francaise contre les Myopathies (AFM). Lancet 1998; 352:347-352.
38. Lofberg M, Liewendahl K, Lamminen A, et al. Antimyosin scintigraphy compared with magnetic resonance imaging in inflammatory myopathies. Arch Neurol 1998; 55:987-993.
39. 99mTc-polyphosphate muscle uptake in a patient with polymyositis: case report. J Nucl Med 1975; 16:1125-1127.
40. 99mTc- pyrophosphate bone scan in polymyositis. Radiology 1977; 122:168.
41. 99mTc-pyrophosphate muscle uptake in patients with inflammatory and noninflammatory muscle diseases. J Nucl Med Allied Sci 1978; 22:89-96.
42. 99m technetium pyrophosphate in patients with neuromuscular disorder: a quantitative study. J Neurol Sci 1982; 53:1-7.
43. 99mtechnetium diphosphonate into degenerating and regenerating muscle: a correlative histological and biochemical study. J Neurol Sci 1981; 51:339-354.
44. 99mTechnetium pyrophosphate scintigraphy in the detection of skeletal muscle disease. Clin Rheumatol 2007; 26:1119-1122.
45. Boulman N, Slobodin G, Rozenbaum M, Rosner I. Calcinosis in rheumatic diseases. Semin Arthritis Rheum 2005; 34:805-812.
46. Bar-Sever Z, Mukamel M, Harel L, Hardoff R. Scintigraphic evaluation of calcinosis in juvenile dermatomyositis with Tc-99m MDP. Clin Nucl Med 2000; 25:1013-1016.
47. Patten C, Meyer RA, Fleckenstein JL. T2 mapping of muscle. Semin Musculoskelet Radiol 2003; 7:297-305.
48. Qi J, Olsen NJ, Price RR, et al. Diffusion-weighted imaging of inflammatory myopathies: polymyositis and dermatomyositis. J Magn Reson Imaging 2008; 27:212-217. This study shows that diffusion-weighted MRI is able to quantify muscle inflammation and capillary perfusion, and this technique is able to simultaneously monitor the integrity of the myofibrillar lattice in myositis.
49. Gold GE. Dynamic and functional imaging of the musculoskeletal system. Semin Musculoskelet Radiol 2003; 7:245-248.
50. Asakawa DS, Blemker SS, Gold GE, Delp SL. Dynamic magnetic resonance imaging of muscle function after surgery. Skeletal Radiol 2006; 35:885-886.
51. Noseworthy MD, Bulte DP, Alfonsi J. BOLD magnetic resonance imaging of skeletal muscle. Semin Musculoskelet Radiol 2003; 7:307-315.
52. Ledermann HP, Schulte AC, Heidecker HG, et al. Blood oxygenation level-dependent magnetic resonance imaging of the skeletal muscle in patients with peripheral arterial occlusive disease. Circulation 2006; 113:2929-2935.
53. Bulte DP, Alfonsi J, Bells S, Noseworthy MD. Vasomodulation of skeletal muscle BOLD signal. J Magn Reson Imaging 2006; 24:886-890.